FLT3 and acute myeloid leukemia: It was found that AML cells presenting FLT3-ITD mutations have enhanced glycolytic activity, primarily due to higher phosphorylation of HK2 localized to mitochondria, favoring ATP transfer from OxPHOS to glycolysis (Ju et al., 2017).